GSK ends 2020 with multi-million dollar deal frenzy to boost R&DGlaxoSmithKline has closed the year with a flurry of deals, leaving its development pipeline bulging like Santa’s sack Share XGSK ends 2020 with multi-million dollar deal frenzy to boost R&Dhttps://pharmaphorum.com/news/gsk-closes-2020-with-four-deals/
